Hyperpolarized xenon MRI may be useful in assessing response to biologic treatment among patients with asthma, according to a ...

AstraZeneca Pharma shares rose on receiving nod from the CDSCO, to import for sale and distribution of Benralizumab 30 mg/ml ...

Through this approval, Benralizumab is indicated as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA).

Bangalore: AstraZeneca Pharma India Limited has received regulatory approval from the Central Drugs Standard Control ...

Investigating allergy prevention, this research highlights early intervention strategies and the promise of biologic ...

More than 50% of patients with severe asthma have high eosinophil levels, making them candidates for biologic therapies like Nucala and other drugs like AstraZeneca’s Fasenra (benralizumab ...

That gives it an advantage over other biologics for severe asthma, such as Sanofi/Regeneron's IL-4/IL-13 inhibitor Dupixent (dupilumab) and AZ's IL-5 inhibitor Fasenra (benralizumab) - which ...

The Indian rupee closed nearly at at 85.5775 versus the U.S. dollar, capping a choppy trading session influenced by routine importer dollar bids and a mild rise in the dollar index. We maintain ...